HLX10

· Shanghai Henlius Biotech

Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for HLX10, covering 2020-03-12 to 2025-12-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy in Patients With ES-SCLC [Phase 3]